Sheep Blood Market
information on sheep blood market
we are currently looking for information regarding international supply of sheep blood for a biologics company. Please get back to us , if you have experience in this sector. We are specifically looking at countries who does pharma grade collection and processing of sheep blood and the list of suppliers who sells the product those regions.
Awaiting a positives response
thank you in advance+12 Other Responses
Biologic Shipping Validation
If the shipping validation of a fda approved biologic manufactured overseas has been successfully completed from site of manufacture to a 3pl to a distributor, and now the 3pl will change, does the validation need to be repeated?+undefined Other Responses
Consulting company currently analyzing the biosimilars industry in cee.
We’re recruiting biosimilar industry experts for interviews related to biosimilars market access (we’re looking to conduct 90-minute interviews for which we’re willing to compensate the interviewees).
Please, see below the list of our key areas of interest. If you feel comfortable with discussing these, please provide the cee countries and respective information areas you are knowledgeable on. Additionally, please provide your requested compensation/rate. Ideally we would like to interview the experts as soon as possible/ this week. We are flexible with time, so it can be early mornings or evening / nights or throughout the day.
Prior to the call we will provide you with a more detailed list of the questions so that you are sure you can discuss these
the interview will focus on 3 areas related to biosimilar market access:
1. Market size – historical and expected biosimilar growth in particular cee countries (overall, relative to originals, by channel, and by biological class)
2. Regulation – market access processes and requirements specific to entering the particular cee country markets (pharmaceutical market authorization, national labelling approval, pricing and reimbursement, substitution and interchangeability)
3. Go to market – sales, logistics and supply chain (key stakeholders and decision makers regarding biosimilar uptake for hospitals and pharmacies, sales/ tender processes in retail and hospital channels, legal requirements, demand creation, wholesaler and distribution economics, etc.)+undefined Other Responses